Results 171 to 180 of about 61,456 (351)

Controlled Ileal Release Budesonide in Pediatric Crohn Disease: Efficacy and Effect on Growth

open access: bronze, 2001
P. Kundhal   +3 more
openalex   +1 more source

Electroacupuncture reshapes the microbial co‐occurrence networks related to the behavioral and psychological symptoms of dementia in Alzheimer's disease

open access: yesiMetaOmics, EarlyView.
Microbial keystone species and gut microbiota composition are highly variable during the pathological development of the behavioral and psychological symptoms of dementia (BPSD) in Alzheimer's disease (AD). Age stratification reveals stage‐specific gut microbial signatures in AD‐related BPSD.
Fu‐You Su   +7 more
wiley   +1 more source

Vulvar Crohn disease: A case report. [PDF]

open access: yesSAGE Open Med Case Rep
Kreutz J, Jensen C, Dytoc M.
europepmc   +1 more source

Crohn's Disease [PDF]

open access: yesProceedings of the Royal Society of Medicine, 1965
openaire   +3 more sources

Predictive Value of Laboratory Assays Toward Autoimmune Diseases

open access: yesJournal of Clinical Laboratory Analysis, EarlyView.
With an increasing number of unmet medical needs for autoimmune diseases (AD) in the United States, it is important to assess the value of laboratory assays in diagnosis. Healthcare providers must understand general and specific laboratory results that can lead to an efficient diagnosis.
Kellen J. Begeman   +3 more
wiley   +1 more source

A Therapeutic Tightrope: Managing Coexisting Crohn Disease and Systemic Lupus Erythematosus With Risankizumab. [PDF]

open access: yesACG Case Rep J
AlAwadhi H   +6 more
europepmc   +1 more source

Monoclonal antibodies against the Crohn´s disease - involved pancreatic autoantigen [PDF]

open access: yes, 1988
Horbach, E.   +5 more
core   +1 more source

Topical Tacrolimus and Crohn Disease

open access: bronze, 2001
Tim Hodgson   +2 more
openalex   +1 more source

Clinical and Biochemical Factors Associated With Infliximab Pharmacokinetics in Adult Patients With Inflammatory Bowel Disease

open access: yesThe Journal of Clinical Pharmacology, EarlyView.
Abstract Many patients with inflammatory bowel disease (IBD) do not adequately respond to infliximab, potentially due to individual differences in pharmacokinetics (PK). This study aimed to identify clinical and biochemical variables associated with infliximab PK.
Ilse A. Pool   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy